Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Bioresource Technology|February 22, 2011
Morphology and reactivity characteristics of char biomass particlesClaudio Avila, Cheng Heng Pang, Tao Wu, et al.Antimicrobial Agents and Chemotherapy|March 24, 2010
Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitroKai Lin, Sylwia Karwowska, Eric Lam, et al.Analytical and Bioanalytical Chemistry|January 22, 2020
Data fusion strategies to combine sensor and multivariate model outputs for multivariate statistical process controlRodrigo R de Oliveira, Claudio Avila, Richard Bourne, et al.Chemical Science|November 9, 2022
Automated stopped-flow library synthesis for rapid optimisation and machine learning directed experimentationClaudio Avila, Carlo Cassani, Thierry Kogej, et al.Talanta|December 31, 2020
Acid number, viscosity and end-point detection in a multiphase high temperature polymerisation process using an online miniaturised MEMS Fabry-Pérot interferometerClaudio Avila, Christos Mantzaridis, Joan Ferré, et al.Psychiatria Danubina|June 7, 2026
Effectiveness of computerized cognitive stimulation in Chilean older adultsNicole Caldichoury, Henry Sánchez, Juan-Carlos Coronado, et al.Hepatology International|October 13, 2011
Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis BSang-Hoon Ahn, Young-Oh Kweon, Seung-Woon Paik, et al.Antimicrobial Agents and Chemotherapy|December 24, 2009
Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis BDong Jin Suh, Soon Ho Um, Eva Herrmann, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis BEdward J Gane, Yuming Wang, Yun-Fan Liaw, et al.Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.Pageof 2